MADISON, Wis.–(BUSINESS WIRE)–Thirty scholarships have been awarded to Wisconsin biohealth companies to attend and exhibit at the International BIO Convention in Boston, MA, June 4-7, 2018. Recipients will receive opportunities to participate in one-on-one partnership meetings, showcase their products, network with industry leaders, and represent Wisconsin’s strength in the biohealth industry.
“This conference presents the unique opportunity for our companies to make connections and showcase their business on an international level”
“This conference presents the unique opportunity for our companies to make connections and showcase their business on an international level,” said Lisa Johnson, CEO of BioForward. “We must continue to support our companies in every way possible to elevate our industry’s impact on integrated health solutions and Wisconsin’s economy.”
The Small Business Scholarship program is managed by BioForward and supported by funds provided by the Wisconsin Economic Development Corporation (WEDC). Scholarship recipients are Wisconsin biohealth companies that demonstrate a positive impact on the biohealth industry and have a financial need.
“WEDC is committed to helping early-stage companies connect with international partners, identify foreign direct investment opportunities and expand their revenue and business in Wisconsin,” said WEDC Vice President of International Business Development Katy Sinnott. “The International BIO Convention will serve as an important opportunity for these businesses to further their R&D efforts and highlight the cutting-edge work that Wisconsin biohealth companies are contributing to the global economy.”
The 2018 BIO scholarship recipients include:
Aldevron serves the biotechnology industry with custom production of nucleic acids, proteins and antibodies.
Alithias provides population health data analytics and patient advocacy services to more than 60 employers covering >60,000 lives.
BloodCenter of Wisconsin (part of Versiti) combines an unparalleled experience in transfusion medicine, transplantation, stem cells and cellular therapies, oncology and genomics, diagnostic lab services, and medical and scientific expertise.
Biomax Informatics specializes in research software for bioinformatics.
BrainXell provides iPSC-derived human neurons to the pharmaceutical industry and other research organizations for CNS drug discovery and development.
Co-D Therapeutics, Inc. is a preclinical stage pharmaceutical company developing novel and transforming combination therapies with high safety profiles to treat cancer.
DNASTAR provides useful, affordable, accessible genomics software to a broad a range of life scientists.
ENDECE has discovered a drug for inducing remyelination in devastating demyelinating diseases such as multiple sclerosis.
Imbed Biosciences is a developing stage tissue engineering company commercializing patented advanced bioresorbable materials for soft-tissue repair and regeneration.
Intense Engineering designs, develops and builds turnkey automated systems, custom equipment and products for life science companies.
Intuitive Biosciences provides diagnostic solutions to improve workflow and provide the most accurate results, providing the expertise needed to rapidly convert or build new multiplex immunoassays.
InvivoSciences Inc. is a pioneering developer of functional human tissues and award-winning high-throughput phenotype analyzer for drug & biomarker discovery.
Jace Biomedical, Inc. is a pre-clinical stage pharmaceutical company developing small molecules for the treatment of Alzheimer’s disease (AD).
NeoClone excels at the discovery and development of single chain and single domain antibodies using phage techniques as well as the ability to molecularly modify antibodies.
NeuroSolis, Inc. is an early-stage company developing NSX-0527 for neurological and psychiatric indications.
Regenerative Medical Solutions provides pluripotent stem cell-derived pancreatic beta cells throughout the world for use in drug discovery, toxicity, efficacy testing and as a potential therapeutic platform for diabetes.
Scarab Genomics commercializes bioengineered E. coli to produce DNA and protein.
Stem Pharm is developing advanced biomaterials for stem cell discovery and therapy applications.
True Process is an ISO 13485 certified healthcare IT firm focused on medical software engineering for connected medical devices.
Yahara Software creates custom enterprise software solutions to optimize workflows, collect and analyze data, and visualize results for their specialized IT needs in the life sciences, healthcare, and biotechnology arenas.
To learn more about the Small Business Scholarship program provided by BioForward and WEDC and future scholarship opportunities, visit https://www.bioforward.org/scholarship-2018/.
About BioForward Wisconsin
BioForward serves as the independent voice of Wisconsin’s biohealth industry, providing services and resources to support the growth of our industry throughout the U.S. and the world. BioForward is the only Wisconsin organization representing over 200 biohealth member companies including biotech, biopharma, medical device, diagnostics, digital health, as well as research institutions, and service providers. Our focus in 2018 is advocating on behalf of Wisconsin’s industry strength in integrated health solutions and research. We have implemented several new initiatives and placed emphasis that BioForward represents this impactful industry for the state of Wisconsin. Visit www.bioforward.org to learn more.
About Wisconsin Economic Development Corporation
The Wisconsin Economic Development Corporation (WEDC) leads economic development efforts for the state by advancing and maximizing opportunities in Wisconsin for businesses, communities and people to thrive in a globally competitive environment. Working with more than 600 regional and local partners, WEDC develops and delivers solutions representative of a highly responsive and coordinated economic development network. Visit wedc.org or follow WEDC on Twitter @WEDCNews to learn more.